linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Shareholdings  
Astrazeneca Pharma India Ltd.
 
BSE Code 506820
ISIN Demat INE203A01020
Book Value 332.64
NSE Code ASTRAZEN
Dividend Yield % 0.39
Market Cap 205837.50
P/E 102.46
EPS 80.36
Face Value 2  
Description ( As On March 2026 )No. of ShareHoldersNo. of Shares% of SharesDemat
Promoter          
  Indian Promoter          
  Foreign Promoter  1  18750000  75  18750000  
  Total Promoter  1  18750000  75  18750000  
          
Non Promoter          
 Institutions          
  Mutual Funds / UTI  16  1415558  5.66  1415558  
  FI/Bank/Insurance  10  14479  0.06  14354  
  Govt          
  FII          
  Other  108  710652  2.84  710652  
  Total Institutions  134  2140689  8.56  2140564  
 Non-Institution          
  Bodies Corporate  266  283131  1.13  283131  
  Individuals          
  NRIs/OCBs  1096  87823  0.35  87323  
  Others  27510  3738357  14.96  3630313  
  Total Non-Institution  28872  4109311  16.44  4000767  
Total Non Promoter  29006  6250000  25  6141331  
          
  Depository Receipts          
          
Grand Total  29007  25000000  100  24891331  
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.